Lactinelle (Lactobacillus Gasseri, Lactobacillus Rhamnosus)

The Lactobacillus strains in Lactinelle colonise the vaginal epithelium and produce lactic acid, which lowers the local pH. This acidic environment inhibits pathogenic microorganisms, allowing beneficial bacteria to dominate and maintain a balanced vaginal ecosystem.

The dosing regimen for Lactinelle is determined by the prescribing healthcare professional. The prescriber will specify the number of vaginal capsules or applicators to use and the frequency based on the individual’s condition and treatment plan.

Safety data for Lactinelle in pregnancy and lactation are limited. Women who are pregnant or breastfeeding should discuss use with their obstetrician or healthcare provider to weigh potential benefits against any unknown risks.

To order Lactinelle, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs) and import documentation.

Lactinelle contains a specific combination of Lactobacillus gasseri and Lactobacillus rhamnosus, strains that are well‑studied for their ability to produce lactic acid and adhere to vaginal cells. Compared with generic multi‑strain products, Lactinelle’s targeted strains may offer more consistent colonisation and pH‑modulating effects.

Lactinelle should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct heat, and avoid exposure to extreme temperatures to maintain bacterial viability.

Lactinelle is administered intravaginally. The prescribed number of capsules or applicators are inserted into the vagina according to the healthcare provider’s instructions, typically using a clean fingertip or an applicator device supplied with the product.

Serious risks, although rare, include severe allergic reactions such as anaphylaxis, persistent pelvic pain, fever, or severe vaginal inflammation. Users should seek immediate medical attention if they experience any of these symptoms.

Individuals with a known hypersensitivity to Lactobacillus gasseri, Lactobacillus rhamnosus, or any excipients in the formulation should avoid Lactinelle. It is also not recommended for severely immunocompromised patients without close medical supervision.